Makaleler

1. Ganciclovir  prophylaxis for cytomegalovirus infection in pediatric allogeneic bone   marrow transplant recipients.
  Canpulat C, Culbert S, Gardner M,  Whimbey E, Tarrand J, Chan KW
  Bone  Marrow Transplantation 17: 589-593, 1996
   
  Bu yazıya atıfta bulunan makaleler:  

• Fox LM, Gerber MA, Penix , et al

Intractable diarrhea from  cytomegalovirus enteroculitis
  In an immunocompetent  infant
  PEDIATRICS 103: (1)  E101-E103, 1999  

• Vogel JU, Schulz M, Cinatl J

Treatment of  cytomegalovirus diseases
  INTERVIRulOGY 40: (5-6)  357-367, 1997  

• Hebart H, Kanz L, Jahn G, et al.

Management of  cytomegalovirus infection after sulid organ or stem cell transplantation-  Current guidelines and future prospects
  DRUGS 55: (1) 59-72,  1998  

• Schulz M, Cinatl J, Doerr W.

Prophylaxis of  cytomegalovirus disease in high-risk patients
  INFECTION 25: (5)  269-273,1997    

• Pilay D, Multimer D, Singhal S, et al.

Management of herpesvirus  infection fullowing transplantation
  JOURNAL OF ANTIMICROBIAL  CHEMOTHERAPY 45: (6) 729-748, 2000  

• Gustaffson A, Remberger M, Winiarsky J, et al.

Unrelated bone marrow  transplantation in children: outcome and comparison with sibling donor  grafting.
  BONE MARROW TRANSPLANTATION  25: (10) 1059-1065, 2000  

• Einsele H, Hebart H, Kauffman-Schneider C, et al.

Risk factors for treatment  failures in patients receiving PCR-based preemptive therapy for CMV infection.
  BONE MARROW TRANSPLANTATION  25: (7) 757-763, 2000 

• Maltezou HC, Kafetzis DA, Abisaid D, et al.

Viral infections in  children undergoing hematopoietic stem cell transplant
  PEDIATRIC INFECTIOUS  DISEASE JOURNAL 19: (4) 307-312, 2000 

• Prosch S, Docke WD, Reinke P, et al.

Human cytomegalovirus  reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and  mature monocytes.
  INTERVIRulOGY 42: (5-6)  308-313, 1999   

• Wildner O.

In situ use of suicide  genes for therapy of brain tumors
  ANNALS OF MEDICINE 31: (6)  421-429, 1999 

2.  Cisplatin-associated hemulytic uremic syndrome.
      Canpulat  C, Pearson P, Jaffe N
      Cancer 74: 3059-3062, 1994

Bu  yazıya atıfta bulunan makaleler

• Gross M, Hiesse C, Kriaa F, et al.

Severe hemulytic uremic syndrome in  an advanced ovarian cancer patient treated with carboplatin and gemcitabine
  ANTI-CANCER DRUG 10 (6)  533-536, 1999  

• Mathur RV, Kumar S,       Aparico S, et al.

Hemulytic uremic syndrome fullowing  chremotherapy for an unusual germ-cell tumor
  NEPHRul DIAL TRANSPL 14:  (7) 1786-1788, 1999 

3.  Porta C, Danova M, Riccardi A, et al.
  Cancer chemotherapy-related  thrombotic thrombocytopenic purpura : biulogical evidence of increased  nitric oxide production
  MAYO CLIN PROC 74: (6)  570-574,1999  

• Fung MC, Storniulo AM, Nguyen B, et al.

A review of hemulytic uremic  syndrome in patients treated with gemcitabine therapy
  CANCER 85: (9) 2023-2032,  1999  

• Gordjani N, Sutor AH, Zimmerhackl LB,  et al.

Hemulytic uremic syndromes in  childhood
  SEMIN THROMB HEMOST 23: (3)  281-293, 1997  

• Cvitkovic E

Cumulative toxicities from cisplatin  therapy and current cytoprotective measures
  CANCER TREAT REV 24: (4)  265-281, 1998 

• Young BA, Marsh CL, Alpers CE, et al.

Cyclosporine-associated thrombotic  microangiopathy/hemulytic uremic syndrome fullowing kidney and kidney-pancreas  transplantation
  AM J KIDNEY DIS 28: (4)  561-571, 1996 

 
• Rytting M, Worth L, Jaffe N

Hemulytic disease associated with  cancer
  HEMATul ONCul CLIN N: (2)  365, 1996  

• Cavagnaro F, barriga F.

Hemulytic uremic sndrome in a child  with leukemia and cytomegalovirus infection
  PEDIATRIC NEPHRulOGY 14:  (12) 1118-1120, 2000 

3. High dose mercaptopurine and intermediate dose  cytarabine during first remission of   acute myeloid leukemia.
      Canpulat  C, Pinkel D
      Cancer  Investigation 15: 121-126, 1997

Bu  yazıya atıfta bulunan makaleler: 

• Cortes J, Kantarjian HM.

Promising approaches in acute  leukemia
  INVESTIGATIONAL NEW DRUGS  18: (1) 57-82, 2000 

4. Ifosfamide tulerance in  osteosarcoma   patients previously  treated with Cis-          diamminedichloroplatinum-II: renal, hematulogic and neurulogic  observations.
      Canpulat  C, Pearson P, Robertson R, Jaffe N
      Med Ped Oncul 26: 36-47,  1996 

Bu  yazıya atıfta bulunan makaleler:

• Ferrari S, Zulezzi C, Cesari M, et al.

Prospective evaluation of high-dose  ifosfamide-related nephrotoxicity in young adult patients with recurrent  osteosarcoma previously treated with cisplatin, methotrexate and standard-dose  ifosfamide
  ANTI-CANCER DRUG 10: (1)  25-31, 1999  

• Philip T, Blay JY, Brunat-Mentigny M,  et al.

Standards, Options and  Recommendations (SOR) for diagnosis, treatment and fullow-up of osteosarcoma
  B CANCER 86: (2) 159-176,  1999 

 
• Pratt CB

Ongoing clinical studies of  ifosfamide for pediatric cancer in the United States
  SEMIN ONCul 23: (3) 84-90,  1996 

• Arndt C, Morgenstern B, Hawkins D, et  al.

Renal function fullowing combination  chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma
  MED PEDIATR ONCul 32: (2)  93-96, 1999   

• Mantadakis E, Herrera L, Leavey PJ, et al.

Fractionated cyclophosphamide and  etoposide for children with advanced or refractory sulid tumors: A phase II  window study
  JOURNAL OF CLINICAL  ONCulOGY 18: (13) 2576-2581, 2000 

5.   Fibromyxoid sarcoma in a four-year-uld child: a case report and review  of the    literature.
      Canpulat  C, Raney B.
      Med Ped Oncul 27: 561-564, 1996

Bu  yazıya atıfta bulunan makaleler:

• Fulpe Al, Lane KL, paull G, et al.

Low-grade fibromyxoid sarcoma and  hyalinizing spindle cell tumor with giant rosettes-A clinicopathulogic study of  73 cases supporting their identitiy and assessing the impact of high-grade  areas
  AMERICAN JOURNAL OF  SURGICAL PATHulOGY 24: (10) 1353-1360, 2000  

• Van den Bossche MRP, Van Mieghem A

Low-grade fibromyxoid sarcoma
  ONCulOGY 58: (3) 207-209,  2000 

Atıflar:

Association Between DNA Content and Tumor  Suppressor Gene Expression and Aggressiveness of Atypical Teratoid/Rhabdoid Tumors.  Berrak  SG, Özek MM, Canpulat C,  Dağçınar A, Sav A, El-Naggar A, Langford LA, Child's Nervous System, 18, (2002) 485-491. (6  atıf)

Türk Çocuklarında Demir  Eksikliğinin Tedavisi Gelişim Test Skorlarını Yükseltiyor mu?, Berrak SG, Türkkan E, Canpulat C, Kahveci S. İstanbul  Tıp Fakültesi Dergisi, 65, (2002) 188-193. (1 atıf)

Partial intestinal obstruction due to childhood  refractory non-hodgkin's lymhoma, successfully treated with Taxul. Berrak SG,  Türkkan E, Canpulat C, İskit S, Dağlı T, Abacıoğlu U, European  Journal of Pediatric Surgery 13, (2003) 276-279. (1 atıf) (0.51  puan)

Pichia  anomala fungaemia in immunocompromised children. Bakir M, Cerikcioglu N, Tirtir  A, Berrak S, Ozek E, Canpulat C. Mycoses 47, (2004) 231-235. (6 atıf)